← All stocks

C4 Therapeutics, Inc.

CCCC Net selling
CIK 0001662579 #3117 in the set updated 21 Sep 2026
Bought (120 mo)
$336.29K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.86M
$3.65K on a plan · $4.16M straight out of an exercise
Sold at will
$12.70M
40 of 54 sales
Net
−$16.52M
−$12.36M against sales at will

By person

21 insiders · 85 transactions
3.4×

Andrew J. Hirsch holds only 3.4 times base salary in stock. $2.39M of shares against $694.93K in salary for 2025.

Salary from the company's own proxy. The shares are what Andrew J. Hirsch last reported holding, valued at $2.22, the price Common Stock was last bought or sold at on the open market here, on 16 Jan 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Prokupets Elena
Director
$8.60M (28)
−$8.60M
1,184,573
0.9629%
$2.63M
+82.3%
Fisher Stewart
Chief Scientific Officer
$3.84M (3)
−$3.84M
130,710
0.1062%
$290.18K
+55.1%
Crystal Adam
Chief Medical Officer
$2.97M (10) scheduled
−$2.97M
20,097
0.0163%
$44.62K
Siegel Jolie
Chief Legal Officer
$1.19M (2) scheduled
−$1.19M
107,939
0.0877%
$239.62K
Salter Malcolm
Director
$24.99K (1)
$239.79K (8)
−$214.80K
11,380
0.0093%
$25.26K
MCKEE WILLIAM
Chief Financial Officer
$100.00K (1)
+$100.00K
5,263
0.0043%
$11.68K
COHEN MARC A
Director
$95.57K (1)
+$95.57K
6,327,970
5.14%
$14.05M
+216.2%
Hirsch Andrew
President & CEO
$84.00K (1)
+$84.00K
1,074,934
0.8738%
$2.39M
Koppikar Utpal
Director
$31.74K (1)
+$31.74K
5,667
0.0046%
$12.58K
REYNO LEONARD
Chief Medical Officer
$22.20K (1)
−$22.20K
372,406
0.3027%
$826.74K
Boyle Scott N
Chief Business Officer
$3.65K (2) scheduled
−$3.65K
298,801
0.2429%
$663.34K
COHEN ALAIN J
Director
4,289,160
3.49%
$9.52M
Dubin Glenn
Director
812,682
0.6606%
$1.80M
+2.8%
DOWNEY BRUCE
Director
489,542
0.3979%
$1.09M
Adams Kendra
Chief Financial Officer
385,098
0.3130%
$854.92K
Mahaney Paige
Chief Scientific Officer
336,910
0.2739%
$747.94K
Schick Kelly
Chief People Officer
299,881
0.2438%
$665.74K
Anderson Kenneth Carl
Director
275,674
0.2241%
$612.00K
+488.9%
GROGAN DONNA ROY
Director
74,853
0.0608%
$166.17K
Mossler Mark
Chief Accounting Officer
71,916
0.0585%
$159.65K
White Lauren
Chief Financial Officer
32,686
0.0266%
$72.56K
Insider
Date
Role
Action
Shares
Price
Amount
Crystal Adam
4 Jan 2022
Chief Medical Officer
Sold after exercise
1,054
$32.66
$34.42K
Crystal Adam
4 Jan 2022
Chief Medical Officer
Sold after exercise
13,946
$31.59
$440.55K
Crystal Adam
1 Oct 2021
Chief Medical Officer
Sold after exercise
5,112
$45.99
$235.12K
Crystal Adam
1 Oct 2021
Chief Medical Officer
Sold after exercise
8,176
$45.32
$370.56K
Crystal Adam
1 Oct 2021
Chief Medical Officer
Sold after exercise
1,712
$44.25
$75.76K
Siegel Jolie
10 Sep 2021
Chief Legal Officer
Sold after exercise
12,500
$50.00
$625.00K
Crystal Adam
29 Jul 2021
Chief Medical Officer
Sold after exercise
15,000
$45.00
$675.00K
Siegel Jolie
29 Jul 2021
Chief Legal Officer
Sold after exercise
12,500
$45.00
$562.50K
Crystal Adam
1 Jul 2021
Chief Medical Officer
Sold after exercise
1,700
$38.38
$65.25K
Crystal Adam
1 Jul 2021
Chief Medical Officer
Sold after exercise
13,300
$37.93
$504.42K
Crystal Adam
5 Apr 2021
Chief Medical Officer
Sold after exercise
10,879
$38.00
$413.41K
Crystal Adam
5 Apr 2021
Chief Medical Officer
Sold after exercise
4,121
$37.16
$153.13K

What was left out

Form 4 filings counted 257
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 12
Sales at will 40
Transactions with no price 0
Shares from compensation/vesting 14,121,215
Sales filed before the plan box existed 39
History held since 5 Oct 2020